ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED VASCULAR EVENTS ARE AN UNDERRECOGNIZED CAUSE OF MORBIDITY AND MORTALITY AFTER LIVER TRANSPLANTATION: BENEFIT OF PLASMAPHERESIS AND ANTICOAGULATION IN TRANSPLANTED PATIENTS WITH HIGH THROMBOTIC RISK Sofía Tejada; Walter González; Eduardo De Santibañes; Ignacio Lucero; Juan Carlos Bandi; Alejandra Villamil;

OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS? Daniela De La Viña; Natalia Sobenko; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi; Maria Alejandra Villamil;

O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS. Alejandra Villamil; Marlene Padilla; Eduardo Mullen; Juan Carlos Bandi; Gabriel Carballo; Natalia Sobenko; Sebastian Marciano;